Lv21
108 积分 2023-10-08 加入
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
8小时前
已完结
骨髓增生异常肿瘤诊断与治疗中国指南（2026年版）
8小时前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
4个月前
已完结
Utility of Thrombopoietin Receptor Agonists for Prolonged Thrombocytopenia After Chimeric Antigen Receptor T-cell Therapy
1年前
已完结
Toxicity and response criteria of the Eastern Cooperative Oncology Group
1年前
已完结
皖公网安备34019202002308
